The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL

International Journal of Oncology

Volumn 38, Issue 6, 2011, Pages 1597-1604

  Na, Y J ^a   Young, Geol Yoon ^a   Jee, Hyun Rho ^a   Jee, Suk Lee ^a   Sang, Yeob Lee ^a   Ki, Soo Yoo ^a   Suhee, Song ^b   Hongsuk, Suh ^b   Yung, Hyun Choi ^c   Young, Hyun Yoo ^a  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Dong Eui University   (South Korea)

Author keywords

Aurora B kinase; Bcl xL; Multinucleation; Polyploidy; Resveratrol analog

Indexed keywords

ANTINEOPLASTIC AGENT; AURORA B KINASE; HS 1793; PHENOL DERIVATIVE; PROTEIN BCL XL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN LNCAP; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; HUMAN; HUMAN CELL; POLYPLOIDY; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-X PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; DRUG SYNERGISM; HCT116 CELLS; HUMANS; K562 CELLS; MALE; NAPHTHOLS; POLYPLOIDY; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RESORCINOLS; U937 CELLS;

EID: 79955874860     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.979     Document Type: Article

References (41)

1. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997. (Pubitemid 127696281)
2. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH and Jin IN: Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22: 1633-1639, 2001.
3. Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, Kofler R, Csordas A and Greil R: Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J 15: 1613-1615, 2001.
4. Trela BC and Waterhouse AL: Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem 44: 1253-1257, 1996. (Pubitemid 126467853)
5. Song S, Lee H, Jin Y, Ha YM, Bae S and Chung HY: Syntheses of hydroxyl substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase. Bioorg Med Chem Lett 17: 461-464, 2007. (Pubitemid 46073741)
6. Jeong SH, Jo WS, Song S, Suh H, Seol SY, Leem SH, Kwon TKand Yoo YH: A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells. Biochem Pharmacol 77: 1337-1347, 2009.
7. Jemal A, Siegel AR, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
8. Hsieh TC, Huang YC and Wu JM: Control of prostate cell growth, DNA damage and repair, and gene expression by resveratrol analogues, in vitro. Carcinogenesis 32: 93-101, 2011.
9. Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA and Davis PJ: Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J Urol 168: 748-755, 2002. (Pubitemid 34793357)
10. Wang Y, Romigh T, He X, Orloff MS, Silverman RH, Heston WD and Eng C: Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines. Hum Mol Genet 19: 4319-4329, 2010.
11. Hsieh TC and Wu JM: Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. Anticancer Res 20: 225-228, 2000.
12. Nigg EA: Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2: 21-32, 2001.
13. Carmena M and Earnshaw WC: The cellular geography of aurora kinases. Nat Rev Mol Cell Biol 4: 842-854, 2003. (Pubitemid 37411723)
14. Andrews PD, Knatko E, Moore WJ and Swedlow JR: Mitotic mechanics: the auroras come into view. Curr Opin Cell Biol 15: 672-683, 2003. (Pubitemid 37487960)
15. Tseng TC, Chen SH, Hsu YP and Tang TK: Protein kinase profile of sperm and eggs: cloning and characterization of two novel testis-specific protein kinases (AIE1, AIE2) related to yeast and fly chromosome segregation regulators. DNA Cell Biol 17: 823-833, 1998.
16. Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F and Terada Y: Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 58: 4811-4816, 1998. (Pubitemid 28503674)
17. Chieffi P, Cozzolino L, Kisslinger A, Libertini S, Staibano S, Mansueto G, De Rosa G, Villacci A, Vitale M, Linardopoulos S, Portella G and Tramontano D: Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66: 326-333, 2006. (Pubitemid 43191232)
18. Wilkinson RW, Odedra R, Heaton SP, Wedge SR, Keen NJ, Crafter C, Foster JR, Brady MC, Bigley A, Brown E, Byth KF, Barrass NC, Mundt KE, Foote KM, Heron NM, Jung FH, Mortlock AA, Boyle FT and Green S: AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin Cancer Res 13: 3682-3688, 2007. (Pubitemid 46955132)
19. Nair JS, de Stanchina E and Schwartz GK: The topoisomerase I poison CPT-11 enhances the effect of the Aurora B kinase inhibitor AZD1152 both in vitro and in vivo. Clin Cancer Res 15: 2022-2030, 2009.
20. Gizatullin F, Yao Y, Kung V, Harding MW, Loda M and Shapiro GI: The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 66: 7668-7677, 2006. (Pubitemid 44289225)
21. Lee EC, Frolov A, Li R, Ayala G and Greenberg NM: Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 66: 4996-5002, 2006. (Pubitemid 43844918)
22. Shah OJ, Lin X, Li L, Huang X, Li J, Anderson MG, Tang H, Rodriguez LE, Warder SE, McLoughlin S, Chen J, Palma J, Glaser KB, Donawho CK, Fesik SW and Shen Y: Bcl-xL respresents a druggabel molecular vulnerability during aurora B inhibitor-mediated polyploidization. Proc Natl Acad Sci USA 107: 12634-12639, 2010.
23. Waizenegger I, Giménez-Abián JF, Wernic D and Peters JM: Regulation of human separase by securing binding and auto-cleavage. Curr Biol 12: 1368-1378, 2002. (Pubitemid 34915538)
24. Minn AJ, Boise LH and Thompson CB: Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 10: 2621-2631, 1996. (Pubitemid 26357228)
25. Lanni JS and Jacks T: Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 18: 1055-1064, 1998. (Pubitemid 28063440)
26. Andreassen PR, Lohez OD, Lacroix FB and Margolis RL: Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 12: 1315-1328, 2001. (Pubitemid 33044413)
27. Guidotti JE, Brégerie O, Robert A, Debey P, Brechot C and Desdouets C: Liver cell polyploidization: a pivotal role for binuclear hepatocytes. J Biol Chem 278: 19095-19101, 2003. (Pubitemid 36799297)
28. Hixon ML, Obejero-Paz C, Muro-Cacho C, Wagner MW, Millie E, Nagy J, Hassold TJ and Gualberto A: Cks1 mediates vascular smooth muscle cell polyploidization, J Biol Chem 275: 40434-40442, 2000. (Pubitemid 32064678)
29. Matzke MA, Mette MF, Kanno T and Matzke AJ: Does the intrinsic instability of aneuploid genomes have a causal role in cancer? Trends Genet 19: 253-256, 2003.
30. Ganem NJ and Pellman D: Limiting the proliferation of polyploid cells. Cell 131: 437-440, 2007. (Pubitemid 350007703)
31. Ricke RM, van Ree JH and van Deursen JM: Whole chromosome instability and cancer: A complex relationship. Trends Genet 24: 457-466, 2008.
32. Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S and Otsu M: AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J 17: 667-676, 1998. (Pubitemid 28062046)
33. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequignot MO, Casares N, Valent A, Mouhamad S, Schmitt E, Modjtahedi N, Vainchenker W, Zitvogel L, Lazar V, Garrido C and Kroemer G: Apoptosis regulation in tetraploid cancer cells. EMBO J 25: 2584-2595, 2006. (Pubitemid 44012240)
34. Hau PM, Siu WY, Wong N, Lai PB and Poon RY: Polyploidization increases the sensitivity to DNA-damaging agents in mammalian cells. FEBS Lett 580: 4727-4736, 2006. (Pubitemid 44189395)
35. Xu WS, Perez G, Ngo L, Gui CY and Marks PA: Induction of polyploidy by histone deacetylase inhibitor: a pathway for anti-tumor effects. Cancer Res 65: 7832-7839, 2005. (Pubitemid 41297259)
36. Hall LL, Th'ng JP, Guo XW, Teplitz RL and Bradbury EM: A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation. Cancer Res 56: 3551-3559, 1996.
37. Reiners JJ Jr, Kleinman M, Joiakim A and Mathieu PA: The chemotherapeutic agents XK469 (2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid) and SH80 (2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid) inhibit cytokinesis and promote polyploidy and induce senescence. J Pharmacol Exp Ther 328: 796-806, 2009.
38. Otto SP: The evolutionary consequences of polyploidy. Cell 131: 452-462, 2007.
39. Rancati G, Pavelka N, Fleharty B, Noll A, Trimble R, Walton K, Perera A, Staehling-Hampton Seidel CW and Li R: Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135: 879-893, 2008.
40. Lee KW, Kang NJ, Rogozin EA, Oh S, Heo YS and Pugliese A: The resveratrol analogue 3,5,30,40,50-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int J Cancer 123: 2487-2496, 2008.
41. Gosslau A, Pabbaraja S, Knapp S and Chen KY: Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. Eur J Pharm 587: 25-34, 2008.